| Date Filed | Type | Description |
| 07/05/2023 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
| 06/28/2022 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.81, valued at
$32.4k
|
|
| 06/29/2021 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 22,677 options to buy
@ $2.92, valued at
$66.2k
|
|
| 12/29/2020 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/22/2020 |
3
| BERMAN DENNIS N (Director) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
| 04/17/2017 |
4
| BERMAN DENNIS N (former director & officer) has filed a Form 4 on Tocagen Inc |
| 04/12/2017 |
3
| BERMAN DENNIS N (EVP, Corp Development) has filed a Form 3 on Tocagen Inc |
| 02/12/2008 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2007 |
SC 13G/A
| BERMAN DENNIS N reports a 8.3% stake in KINTERA, INC. |
| 05/18/2006 |
4
| BERMAN DENNIS N (Executive VP, Corp Dev) has filed a Form 4 on KINTERA INC|
Txns:
| Bought 10,000 shares
@ $1.18, valued at
$11.8k
|
|
| 03/10/2006 |
4
| BERMAN DENNIS N (Executive VP, Corp Dev) has filed a Form 4 on KINTERA INC|
Txns:
| Granted 50,000 options to buy
@ $2.13, valued at
$106.5k
|
|
| 02/13/2006 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/13/2006 |
SC 13G
| BERMAN DENNIS N reports a 10.5% stake in KINTERA, INC. |
| 02/14/2005 |
SC 13G
| BERMAN DENNIS N reports a 10.7% stake in KINTERA, INC. |
| 10/20/2004 |
4
| BERMAN DENNIS N (Exec VP & Vice COB of Dir.) has filed a Form 4 on KINTERA INC|
Txns:
| Granted 200,000 options to buy
@ $7.7, valued at
$1.5M
|
|
| 02/13/2004 |
SC 13G
| BERMAN DENNIS N reports a 14% stake in Kintera, Inc. |